Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Debt Ratio: 2023-2025

Historic Debt Ratio for Xeris Biopharma Holdings (XERS) over the last 3 years, with Sep 2025 value amounting to 0.59.

  • Xeris Biopharma Holdings' Debt Ratio rose 1164.31% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year increase of 1164.31%. This contributed to the annual value of 0.72 for FY2024, which is 10.35% up from last year.
  • As of Q3 2025, Xeris Biopharma Holdings' Debt Ratio stood at 0.59, which was down 9.24% from 0.65 recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Debt Ratio registered a high of 0.73 during Q1 2025, and its lowest value of 0.00 during Q2 2024.
  • Moreover, its 3-year median value for Debt Ratio was 0.05 (2023), whereas its average is 0.32.
  • Per our database at Business Quant, Xeris Biopharma Holdings' Debt Ratio slumped by 97.50% in 2024 and then skyrocketed by 51,494.53% in 2025.
  • Quarterly analysis of 3 years shows Xeris Biopharma Holdings' Debt Ratio stood at 0.65 in 2023, then grew by 10.35% to 0.72 in 2024, then surged by 1,164.31% to 0.59 in 2025.
  • Its last three reported values are 0.59 in Q3 2025, 0.65 for Q2 2025, and 0.73 during Q1 2025.